Manulife (Manufacturers Life Insurance)
PSTX

Manulife (Manufacturers Life Insurance)’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-25,455
Closed -$244K – 3024
2024
Q4 		$244K Sell
25,455
-1,818
-7% -$9.48K ﹤0.01% 2534
2024
Q3 		$78K Sell
27,273
-1,247
-4% -$3.86K ﹤0.01% 2921
2024
Q2 		$83.3K Buy
28,520
+3,552
+14% +$9.71K ﹤0.01% 2869
2024
Q1 		$79.6K Sell
24,968
-3,065
-11% -$10.2K ﹤0.01% 2829
2023
Q4 		$94.2K Sell
28,033
-2,363
-8% -$6.09K ﹤0.01% 2835
2023
Q3 		$72.3K Hold
30,396
– – ﹤0.01% 2892
2023
Q2 		$53.5K Buy
+30,396
New +$77.6K ﹤0.01% 2946
2022
Q2 		– Sell
-14,614
Closed -$65.5K – 3171
2022
Q1 		$65.5K Buy
+14,614
New +$65.9K ﹤0.01% 3016
2021
Q3 		– Sell
-19,599
Closed -$196K – 3235
2021
Q2 		$196K Sell
19,599
-664
-3% -$5.95K ﹤0.01% 3121
2021
Q1 		$194K Buy
+20,263
New +$199K ﹤0.01% 2903

Other funds holding PSTX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s PSTX Position: Q1 2025 in Review

Manulife (Manufacturers Life Insurance) sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 25,455 shares — an estimated $244K sold.

Manulife (Manufacturers Life Insurance) first reported a position in PSTX in Q1 2021 and held it in 10 quarters. The position peaked at $244K in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

  • Manulife (Manufacturers Life Insurance) reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 25,455 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $244K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Poseida Therapeutics, Inc. Common Stock in Q1 2021 and held it in 10 quarters.
  • Manulife (Manufacturers Life Insurance)'s Poseida Therapeutics, Inc. Common Stock position peaked at $244K in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2025, filed 15 May 2025.